Obstructive Sleep Apnea (OSA) is a prevalent sleep-related breathing disorder in adult associated with significant cardiometabolic and neurocognitive morbidity. Despite, its high prevalence, adult OSA remains underdiagnosed globally. Diagnostic challenges arise multifaceted factors across the healthcare. The screening tools correlate poorly with objective physiological severity particularly for women and younger adults. The currently available screening tools have low specificity for diagnosis of OSA.Barrier for OSA diagnosis, including limited access to gold standard in-laboratory polysomnography, high cost, specialist shortage and socioeconomic disparities in screening. Overcoming the diagnostic gap in adult OSA requires a paradigm shift toward broader clinical recognition of heterogeneous symptom phenotypes, expended integration of validated home sleep apnea testing and AI-integrated teachnique.